30 closest matches · ranked by relevance
Cobalt Biokinetics · Safety of Cobalt Dietary Supplementation
Primary: Cobalt Whole Blood Concentrations — 14.6; 7.4; 33.9; 8.5 µg Co/L
Bipolar Depression
Primary: Mean Concentrations of Cerebral Energetic Metabolites in Geriatric BPD and Older Controls at Baseline — 4.35; 3.94; 3.23; 3.06 Integration Expressed as Arbitrary Unit
Smoking, Tobacco
Primary: Performance Variable - Correlation of Carbon Monoxide (CO) Measurements Between COBSS and Predicate Devices — 0.9878 Correlation coefficient (R-value)
Healthy
Primary: Change in Sodium Blood Levels — -0.1; 0.2 mmol/L
Peripheral Vascular Disease
Primary: Major Adverse Events (MAE), Measured as Device and/or Procedure Related Death, Target Limb Loss and/or Clinically Driven Target Lesion Revascularization (TLR) or Target…
Bipolar Depression
Primary: We Measured the Change in Rate Constant of Creatine Kinase in Individuals With Bipolar Depression Treated With CoQ 10 as Compared With Age and Gender Matched Controls…
Healthy Volunteers
Primary: Absolute Bioavailability of PBT2 (F%) — 15.936 percentage of absolute bioavailability
Osteoarthritis · Avascular Necrosis · Rheumatoid Arthritis
Primary: Cobalt Chromium Levels — 1.06 micrograms/dl
Amyotrophic Lateral Sclerosis
Primary: Electromyography Measures of Disease Progression. — -39.6; -31.8 percent change — p=0.4304
Hypercholesteremia
Primary: Percent Change From Baseline in LDL-C at Day 28 — -25.54 Percent Change — p=0.0041
Healthy
Primary: Change Sodium Blood Levels — 141.8; 141.2 mmol/L
Sarcopenia · Gait Disorders in Old Age · Muscle Weakness
Primary: Change From Baseline to 6 Months in Gait Speed for 400 Meter Walking (MW) Test — 0.0093; 0.0457; 0.0478; -0.2886 Meter/Second (m/s) — p=0.2437
Concussion
Primary: Longitudinal DTI Changes — 0.000809; 0.000760; 0.000763; 0.000843 voxels
Chronic Kidney Disease · Sarcopenia · Frailty
Primary: Maximal Aerobic Capacity- CoQ10 — 21.4; 20.7; 20.7 mL/min/kg — p=0.33
Refractive Errors · Ametropia
Primary: Average Percent Area of Solution-related Corneal Staining — 7.01; 12.82; 13.54; 7.58 percentage of area
Anemia, Sickle Cell
Primary: Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) — 0; 0; 0; 0 Participants
Myopathy · HMG COA Reductase Inhibitor Adverse Reaction · Hypercholesterolemia
Primary: Phosphocreatine Recovery — -18.9; 7.7 percentage change from baseline
Aging · Sedentary Lifestyle · Frailty
Primary: Skeletal Muscle Mitochondrial Respiration State 3; Baseline to 12-week Change. — 2.2; -0.8 pmol O2/s/mg DW — p=0.9017
Healthy
Primary: Mass Balance Recovery of Total Radioactivity in Urine and Faeces: Amount Excreted Within the Time Interval From 0 to the Time of the Last Quantifiable Data Point as a…
Healthy
Primary: Area Under the Concentration-time Curve of BI 409306 and Stable Labelled Isotope BI 409306 (C-13/N-15) Over the Time Interval From 0 Extrapolated to Infinity (AUC0-∞)…
Healthy Volunteers
Primary: Area Under the Curve From Time Zero to Extrapolated Infinite Time (AUCinf) — 780; 717; 858 nanograms*hours/milliliter (ng*hr/mL)
Non-inflammatory Degenerative Joint Disease · Osteoarthritis · Avascular Necrosis
Primary: Post-Operative 5-Year Device Survivorship — 95.3 Percentage of implants
Osteoarthritis, Knee
Primary: Serum Biomarkers — 130; 114; 109; 63 pg/ml
Lower Limb Injury
Primary: Self-Selected Walking Speed Using Hip Exoskeleton Assistance Across Different Locomotion Modes — 1.14; 1.26; 1.26; 0.61 meters per second — p=0.9547
Phosphorus and Calcium Disorders · Chronic Kidney Disease Mineral and Bone Disorder · Chronic Kidney Diseases
Primary: Fractional Calcium Absorption — 0.30; 0.42 fraction of 1.00
Gulf War Illness · Chronic Fatigue · Ubiquinol
Primary: Veterans Short Form 36-Item Health Survey Physical Component Summary — 1.6; -1.1; 1.4; 1.1 units on a scale
Healthy Volunteer
Primary: Maximum Observed Plasma Concentration (Cmax) — 10.7; 9.00; 8.03; 3.97 nanograms per milliliter (ng/mL)
Distorted; Balance · Sensation Disorders · Peripheral Neuropathy
Primary: Functional Gait Assessment (FGA) — 17; 7 Participants
Missing Teeth · Dental Wear
Primary: Change in Patient Oral Health-related Quality — 9.01; 14.41 score on a scale
Stenosis
Primary: Device Success in the Target Lesion as Determined by the Angiographic Core Laboratory — 58 Participants